sheila
2 years 11 months ago
Dr. Iyer - factors driving inequity in the access of essential medicines esp. in low to middle-income countries:
💠availability
💠affordability
💠accessibility
💠acceptability
#ACR23 @RheumNow @rheumarhyme https://t.co/eIvOAjg31H
TheDaoIndex KDAO2011
2 years 11 months ago
Inequities in Medical Care Delivery:
👉>80% of people live in low/middle income places
👉2 billion people are unable to access meds and healthcare services
👉Availability, accessibility, affordability, acceptability are the 4 barriers
Dr. J Iyer #ACR23 @RheumNow #GlobalSummit https://t.co/u21NTAYBpY
TheDaoIndex KDAO2011
2 years 11 months ago
Big Pharma – Pay attention! When developing new therapeutics, consider delivery, cost, climate sensitivity and sustainability #GlobalSummit @ACRheum @rheumnow #ACR23 https://t.co/ThqnTI3SNm
TheDaoIndex KDAO2011
2 years 11 months ago
Opportunities to address healthcare inequities: generics/biosimilars, fair pricing, and inclusive business models. #GlobalSummit @RheumNow #ACR23 @ACRheum https://t.co/ynJWWcCqWo
Dr. John Cush RheumNow
2 years 11 months ago
Retrospective study(2016-2019) of referred newly, suspected (#RA) pts found no value in initial Xrays. Only 32/724 patients (4.4%) had RA like erosions, with Erosions leading to a Dx in only 2 pts (0.3%) & changed prognostic classification in 3 pts (0.4%) https://t.co/fi48WiBgIc https://t.co/skObArXYr6
Dr. John Cush RheumNow
2 years 11 months ago
Orthopedic cohort study of 274,403 pts (180K females, 94K males; mean age=55). The risk of future TKA was signif greater in pts w/ combination of Depression+Obesity group (11.9%); compared to Controls (8.3%), obese (10.2%) or Depression (7.8%) https://t.co/dltVS0Y6PY https://t.co/REgO5tjEUv
Dr. Jack Cush reviews this past week's news on RheumNow.com and suggests a learning plan for those wanting to consume the upcoming ACR Convergence 2023 meeting.
Dr. John Cush RheumNow
2 years 11 months ago
RHEUM SURVEY: Your choice of a biologic in SpA patients is mostly influenced by? Respond here>> https://t.co/AtX4vZBvIT https://t.co/CgzROe8irB
Research work from the Accelerating Medicines Partnership (AMP: RA/SLE) Network, was published in Nature and more specifically characterizes RA synovium into several cell-type abundance phenotypes (CTAPs). Could CTAPs known disease features or more effective future therapies?
A recent CDC reports estimates that in 2019–2021, 21% of U.S. adults (53.2 million) have physician diagnosed arthritis. Now, an updated report shows a larger number (~33%) of U.S. veterans having diagnosed arthritis. Compared to nonveterans, this prevalence was double in men, and 60% higher in women.
Dr. John Cush RheumNow
2 years 11 months ago
Introducing RheumNow's #ACR23 faculty! They'll be covering ACR this weekend with valuable tweets, articles, videos and more. Follow us for real time updates. https://t.co/c9jla43lqw
Dr. John Cush RheumNow
2 years 11 months ago
QD Clinics - Neighbor Consults
Your neighbor has a Swollen RPIP4.
QD Clinics are sponsored by RheumNows Coverage of #ACR23 live from San Diego
https://t.co/ZXNalfiVFv https://t.co/TAxpVyowF5
Dr. John Cush RheumNow
2 years 11 months ago
Patients Don't Read Textbooks
RA patient unresponsive to biologics, now has enthesitis; what to do?
QD Clinics are sponsored by RheumNows Coverage of #ACR23 live from San Diego
https://t.co/hlacYXm0Nh https://t.co/52Xy3E8kXi
